Topic · page 5 of 12

Across rheumatic diseases

Only studies that genuinely span several rheumatic diseases, such as drug safety and pharmacovigilance, infection, vaccination and comorbidity (cardiovascular, cancer, mental health) across diseases, and health services and quality of care across diseases. Never a fallback for an article that is hard to place

Briefs 161–200 of 474 placed here, newest publication first

Briefs in Across rheumatic diseases

Newest publication first

Ann Rheum Dis26 Apr 2025
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
Guideline or statement
Rheumatology (Oxford)23 Apr 2025
Real-world care patterns and specialist encounters of patients with systemic autoimmune rheumatic disease-related interstitial lung disease in the United States: a retrospective administrative claims database analysis
Cohort study
Ann Rheum Dis16 Apr 2025
Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations
Meta-analysis
Ann Rheum Dis15 Apr 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024
Research article
J Rheumatol15 Apr 2025
Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology Practice
Cohort study
Semin Arthritis Rheum11 Apr 2025
Clinical prediction models for medication adverse events in patients with rheumatic and musculoskeletal conditions: A systematic literature review
Research article
RMD Open9 Apr 2025
Integration of transcriptome and immunophenotyping data highlights differences in the pathogenetic kinetics of B cells across immune-mediated disease
Mechanistic study
Arthritis Res Ther1 Apr 2025
Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis
Cross-sectional study
Rheumatology (Oxford)1 Apr 2025
Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data
Cohort study
Arthritis Care Res (Hoboken)21 Mar 2025
Effectiveness of a Telephone‐Delivered Walk With Ease Program on Arthritis‐Related Symptoms, Function, and Activity: A Randomized Trial
Randomized controlled trial
J Rheumatol15 Mar 2025
Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital System: An Investigation of Ordering Practices and Rheumatologic Outcomes
Cohort study
Joint Bone Spine14 Mar 2025
Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study
Cohort study
Rheumatology (Oxford)11 Mar 2025
Association of oral opioid usage and mortality in patients with inflammatory arthritides: a Korean nationwide cohort study
Cohort study
RMD Open5 Mar 2025
Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study
Cohort study
Ann Rheum Dis3 Mar 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
Guideline or statement
Rheumatology (Oxford)3 Mar 2025
‘I still can’t forget those words’: mixed methods study of the persisting impact on patients reporting psychosomatic and psychiatric misdiagnoses
Research article
J Rheumatol1 Mar 2025
Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study
Cohort study
Rheumatology (Oxford)24 Feb 2025
Abatacept and the risk of malignancy: a meta-analysis across disease indications
Meta-analysis
Semin Arthritis Rheum24 Feb 2025
Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases
Cohort study
Clin Exp Rheumatol24 Feb 2025
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseases
Cohort study
Semin Arthritis Rheum22 Feb 2025
What outcomes are important to people with foot and ankle disorders in rheumatic and musculoskeletal diseases? An OMERACT qualitative interview study across four continents
Research article
Semin Arthritis Rheum14 Feb 2025
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance
Cohort study
Semin Arthritis Rheum11 Feb 2025
Impact of long COVID on self-reported disease activity, disability, and quality of life in individuals with inflammatory arthritis
Cohort study
Ann Rheum Dis10 Feb 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases – a systematic literature review informing the 2024 update of an international expert consensus statement
Research article
Ann Rheum Dis10 Feb 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement
Research article
Scand J Rheumatol4 Feb 2025
Work in the picture? The reporting of and effects on work outcomes in exercise therapy trials in people with rheumatoid arthritis or axial spondyloarthritis: a systematic review
Meta-analysis
Rheumatology (Oxford)25 Jan 2025
Development of START, a novel multimedia-based symptom appraisal tool for autoimmune rheumatic diseases
Diagnostic or prognostic study
Rheumatology (Oxford)25 Jan 2025
Predictive value of insulin resistance metabolic score for cardiovascular disease in Chinese arthritis patients: a prospective cohort study
Cohort study
RMD Open25 Jan 2025
Trends in work participation among patients with inflammatory rheumatic musculoskeletal diseases (iRMDs): Data from the German National Database (2010–2022)
Cross-sectional study
Lancet25 Jan 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study
Cohort study
Clin Exp Rheumatol23 Jan 2025
Stressful life events are associated with the diagnosis of systemic autoimmune rheumatic diseases among adults
Case-control study
Clin Exp Rheumatol22 Jan 2025
Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases
Diagnostic or prognostic study
Arthritis Res Ther21 Jan 2025
Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
Cohort study
Clin Exp Rheumatol13 Jan 2025
Source of vaccine information and trust in health care professionals influence vaccine hesitancy in rheumatology patients in Italy
Cross-sectional study
Arthritis Res Ther10 Jan 2025
Eltrombopag for the treatment of refractory connective tissue disease-related thrombocytopenia: a pilot study of 52 cases
Cohort study
RMD Open6 Jan 2025
Reference intervals of work ability and productivity loss and their use in patients with inflammatory rheumatic and musculoskeletal diseases
Cross-sectional study
Ann Rheum Dis2 Jan 2025
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Mechanistic study
Rheumatology (Oxford)28 Dec 2024
The impact of an online, lifestyle intervention programme on the lives of patients with a rheumatic and musculoskeletal disease: a pilot study
Research article
Arthritis Care Res (Hoboken)17 Dec 2024
Area‐Level Socioeconomic Status Impacts Health Care Visit Frequency by Australian Patients With Inflammatory Arthritis: Results From the Australian Rheumatology Association Database
Cohort study
J Rheumatol15 Dec 2024
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
Cohort study

All 474 Briefs in ExploreShowing Briefs 161–200 of 474, newest first